| Tristan Edwards is the Co-Founder and CEO of Entheos Labs, a biotech company that is changing the future of mental health treatment by advancing the neuroscience of psychedelic medicines. Entheos Labs is focused on developing innovative treatments that are designed to help those who suffer from mood, anxiety, trauma-based, and substance use disorders. Tristan is also the co-founding CEO and now serves as President of Life Biosciences which advances scientific research and develops innovative new therapies to improve and extend healthy lives for everyone. The company was formed with the collection of leading scientists and companies who focus on the eight biological causes of aging, and now leads the world in cellular reprogramming. Originally from Australia, Tristan is a dynamic investor and global business leader, who has a multi-disciplinary approach to building companies from the ground up. Prior to Life Biosciences, he founded and served as Chief Investment Officer for Mosaic Asset Management, a Singapore-based investment company focusing on Asian equities. Tristan began his career with the Australian Commonwealth Department of Finance and had investment roles with Goldman Sachs and Brevan Howard Asset Management. He also managed a significant portfolio at Trafalgar Capital. Tristan currently serves as the co-founder and Chairman of Proto Axiom, Australia’s pre-eminent biotechnology incubator. |
Tristan Edwards
